Patents by Inventor Delphine Haouzi

Delphine Haouzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for assessing pregnancy outcome
    Patent number: 11230736
    Abstract: The invention relates to a method of assessing pregnancy outcome. The inventors investigated endometrial miRNAs associated with pregnancy outcome by studying miRNAs associated with endometrial receptivity, implantation failure and embryo miscarriage. They performed a miRNomic study to find miRNAs that are differentially expressed according to the endometrial receptivity status, compared the endometrial miRNome between receptive patients with negative beta-hCG and receptive patients with positive beta-hCG, and compared the endometrial miRNome between receptive patients with a miscarriage between 8-12 weeks of amenorrhoea and receptive patients with a live birth. They demonstrated miRNA differential expression in endometrial samples according to the pregnancy outcome.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: January 25, 2022
    Assignees: INSERM (Institut National de la Santé de la Recherche Médicale), Université de Montpellier, Centre Hospitalier Universitaire de Montpellier
    Inventors: Samir Hamamah, Delphine Haouzi
  • METHODS FOR ASSESSING PREGNANCY OUTCOME
    Publication number: 20200040395
    Abstract: The invention relates to a method of assessing pregnancy outcome. The inventors investigated endometrial miRNAs associated with pregnancy outcome by studying miRNAs associated with endometrial receptivity, implantation failure and embryo miscarriage. They performed a miRNomic study to find miRNAs that are differentially expressed according to the endometrial receptivity status, compared the endometrial miRNome between receptive patients with negative beta-hCG and receptive patients with positive beta-hCG, and compared the endometrial miRNome between receptive patients with a miscarriage between 8-12 weeks of amenorrhoea and receptive patients with a live birth. They demonstrated miRNA differential expression in endometrial samples according to the pregnancy outcome.
    Type: Application
    Filed: March 28, 2018
    Publication date: February 6, 2020
    Inventors: Samir HAMAMAH, Delphine HAOUZI
  • Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
    Patent number: 9453259
    Abstract: Disclosed herein are methods and kits for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation. More particularly, provided herein is a method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step consisting of measuring the expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from the patient wherein the genes are FGFBP1, MUC20, TMPRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: September 27, 2016
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER 1, Centre Hospitalier Universitaire de Montpellier
    Inventors: Samir Hamamah, Delphine Haouzi
  • Methods for assessing endometrium receptivity of a patient
    Patent number: 9260748
    Abstract: The present invention relates to a method for assessing the endometrium receptivity of a patient, comprising a step consisting of measuring the expression level of eleven genes in an endometrial biopsy sample obtained from said patient wherein said genes are MFAP5, ANGPTL1, PROK1, NLF2, LAMB3, BCL2L10, CD68, TRPC4, SORCS1, FST and KRT80.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: February 16, 2016
    Assignee: Institut National de la Santé et de la Recherche Médicale
    Inventors: Samir Hamamah, Delphine Haouzi
  • METHODS FOR ASSESSING ENDOMETRIAL RECEPTIVITY OF A PATIENT AFTER CONTROLLED OVARIAN HYPERSTIMULATION
    Publication number: 20140371092
    Abstract: The present invention relates to methods and kits for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation. More particularly, the invention relates to a method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step consisting of measuring the expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from said patient wherein said genes are FGFBP1, MUC20, TM-PRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1.
    Type: Application
    Filed: October 22, 2012
    Publication date: December 18, 2014
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER 1
    Inventors: Samir Hamamah, Delphine Haouzi
  • METHODS FOR ASSESSING ENDOMETRIUM RECEPTIVITY OF A PATIENT
    Publication number: 20130072748
    Abstract: The present invention relates to a method for assessing the endometrium receptivity of a patient, comprising a step consisting of measuring the expression level of eleven genes in an endometrial biopsy sample obtained from said patient wherein said genes are MFAP5, ANGPTL1, PROK1, NLF2, LAMB3, BCL2L10, CD68, TRPC4, SORCS1, FST and KRT80.
    Type: Application
    Filed: May 27, 2011
    Publication date: March 21, 2013
    Inventors: Samir Hamamah, Delphine Haouzi